Clinical Trial Update: The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD) [NA]

View source ↗

Summary

Completed clinical trial evaluating the effect of bezafibrate on very long chain fatty acid (VLCFA) levels in X-linked adrenoleukodystrophy and adrenomyeloneuro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenomyeloneuropathy
• X-linked Adrenoleukodystrophy

Drugs mentioned

• Bezafibrate (bezafibrate)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: X-linked Adrenoleukodystrophy, Adrenomyeloneuropathy | NA | Status: COMPLETED